← Back to guidelines
Cardiology7 papers

Postprocedural aortic valve regurgitation

Last edited: 4/10/2026

Overview

Postprocedural aortic valve regurgitation (AR) is a complication that can occur after aortic valve interventions. The severity and management of AR depend on the underlying cause and patient factors.

Diagnosis

  • Grading of AR is typically performed using echocardiography, assessing parameters such as jet area, vena contracta width, and pressure half-time 1.
  • Management

  • Management strategies for postprocedural AR are guided by the severity of regurgitation and the patient's clinical status.
  • Key Recommendations

  • Estimated plasma volume status (ePVS) may be used to refine risk stratification and candidate selection for transcatheter aortic valve implantation (TAVI) 1.
  • High ePVS is associated with an increased risk of 1-year all-cause mortality in patients undergoing TAVI 1.
  • High ePVS is associated with increased unadjusted odds for 30-day mortality, peri-procedural stroke, major bleeding, and acute kidney injury in TAVI patients 1.
  • The unadjusted risk of pacemaker implantation and major vascular complications did not differ significantly between high and low ePVS groups in TAVI patients 1.
  • References

    1 Papazoglou AS, Moysidis DV, Anastasiou V, Daios S, Kamperidis V, Ziakas A et al.. Prognostic relevance of pre-procedural plasma volume status estimation in patients undergoing transcatheter aortic valve implantation: A meta-analysis. Current problems in cardiology 2024. link

    Original source

    1. [1]
      Prognostic relevance of pre-procedural plasma volume status estimation in patients undergoing transcatheter aortic valve implantation: A meta-analysis.Papazoglou AS, Moysidis DV, Anastasiou V, Daios S, Kamperidis V, Ziakas A et al. Current problems in cardiology (2024)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG